Education
About Us
Working with TipRanks
Follow Us
XHE - ETF AI Analysis
Top Page
SPDR S&P Health Care Equipment ETF (XHE)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Top Holdings Performance
Several of the largest positions, such as Neogen and UFP Technologies, have shown strong gains this year, helping support the fund’s overall results.
Focused Health Care Equipment Exposure
The ETF is heavily focused on health care equipment companies, giving investors targeted exposure to a specialized and growing part of the health care sector.
Moderate Expense Ratio
The fund’s expense ratio is moderate for a specialized sector ETF, so fees are not excessively high relative to its niche focus.
Negative Factors
Single-Sector Concentration
Almost all assets are in the health care sector, which increases risk if this industry faces a downturn.
U.S.-Only Geographic Exposure
The ETF is almost entirely invested in U.S. companies, offering little diversification across global markets.
Mixed Recent Performance
While three-month returns have been strong, the ETF’s year-to-date and one-month results have been relatively weak, showing some recent volatility.
XHE vs. SPDR S&P 500 ETF (SPY)
AUM147.06M
RegionNorth America
Expense Ratio0.35%
Beta0.80
IssuerSPDR
Inception DateJan 26, 2011
Dividend Yield0.08%
Asset ClassEquity
Index TrackedS&P Healthcare Equipment Select Industry
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume11,534
30 Day Avg. Volume18,233
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
108.03Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering64
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XHE Summary
XHE is an ETF that follows the S&P Health Care Equipment Select Industry Index, focusing on U.S. companies that make medical devices, tools, and supplies used in hospitals and clinics. It holds a wide mix of health care equipment makers, including names like Neogen and Penumbra, giving you a way to invest in medical technology without picking individual stocks. Someone might consider XHE for long-term growth potential as health care needs and innovation continue to rise. However, the fund is heavily focused on one sector, so its price can swing with changes in the health care industry.
How much will it cost me?The SPDR S&P Health Care Equipment ETF (XHE) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is a sector-focused fund, which often requires more active management compared to broad-market index funds. However, it provides targeted exposure to the innovative health care equipment industry.
What would affect this ETF?The SPDR S&P Health Care Equipment ETF (XHE) could benefit from increased demand for innovative medical technologies and devices, driven by aging populations and advancements in health care. However, it may face challenges from regulatory changes, rising interest rates that impact growth-focused companies, or economic slowdowns that reduce health care spending. Its U.S.-focused portfolio and reliance on the health care equipment sector make it sensitive to domestic policy shifts and sector-specific trends.
XHE Top 10 Holdings
XHE is a pure U.S. medical‑equipment play, and its story right now is all about innovative but volatile mid-cap names. High-flyers like Butterfly Network, Glaukos, and Omnicell have been rising sharply, helping pull the fund higher as investors bet on new devices and AI-driven tools. Penumbra and UFP Technologies add steady momentum with solid growth in core MedTech markets. On the flip side, Neogen and QuidelOrtho look like they’re stuck in the mud, with financial challenges that keep them from fully joining the rally.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Neogen | 2.65% | $3.88M | $2.23B | -3.48% | 50 Neutral | |
| Ufp Technologies | 2.16% | $3.16M | $1.97B | -10.11% | 75 Outperform | |
| Integer Holdings | 2.14% | $3.14M | $3.00B | -38.28% | 65 Neutral | |
| Penumbra | 2.12% | $3.11M | $14.00B | 35.82% | 78 Outperform | |
| AxoGen | 2.10% | $3.09M | $1.76B | 94.74% | 69 Neutral | |
| Omnicell | 2.00% | $2.93M | $2.19B | 4.99% | 71 Outperform | |
| Lantheus | 1.97% | $2.89M | $4.41B | -28.10% | 73 Outperform | |
| Baxter International | 1.96% | $2.88M | $10.21B | -36.63% | 45 Neutral | |
| Glaukos | 1.95% | $2.86M | $6.75B | -23.44% | 61 Neutral | |
| Dexcom | 1.93% | $2.84M | $28.29B | -18.10% | 79 Outperform |
XHE Technical Analysis
Negative
―
Price Trends
88.80
Negative
84.54
Positive
82.40
Positive
Market Momentum
-0.81
Positive
35.83
Neutral
12.12
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XHE, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 88.70, equal to the 50-day MA of 88.80, and equal to the 200-day MA of 82.40, indicating a neutral trend. The MACD of -0.81 indicates Positive momentum. The RSI at 35.83 is Neutral, neither overbought nor oversold. The STOCH value of 12.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XHE.
XHE Peer Comparison
Comparison Results
Performance Comparison
XHE
SPDR S&P Health Care Equipment ETF
85.38
-10.26
-10.73%
IHE
iShares U.S. Pharmaceuticals ETF
―
―
―
FXH
First Trust Health Care AlphaDEX Fund
―
―
―
RSPH
Invesco S&P 500 Equal Weight Health Care ETF
―
―
―
IHF
iShares U.S. Healthcare Providers ETF
―
―
―
PJP
Invesco Dynamic Pharmaceuticals ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents